Microbial Identification Market Report 2025

This Microbial Identification market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The microbial identification market size has grown rapidly in recent years. It will grow from $5.57 billion in 2024 to $6.44 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to government initiatives and funding for promoting microbial identification, growing FDA approvals, growing health awareness among people.

The microbial identification market size is expected to see rapid growth in the next few years. It will grow to $11.44 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to growing food safety concerns, rising incidence of infectious diseases and increasing frequency of pandemics. Major trends in the forecast period include technological advancements in microbial identification methods, continuous advancements in automation, molecular diagnostics, and genomics, partnerships.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the microbial identification market in the coming years. Infectious diseases, caused by pathogenic microorganisms like bacteria, viruses, fungi, parasites, or prions, are influenced by factors such as climate change, environmental disruption, antimicrobial resistance, weakened immune systems, and ecological changes. Microbial identification plays a crucial role in accurately diagnosing infections, enabling targeted treatments, monitoring diseases, controlling outbreaks, and supporting antimicrobial stewardship. For example, in March 2024, the Centers for Disease Control and Prevention (CDC) reported an increase in tuberculosis cases in the US, rising from 8,320 in 2022 to 9,615 in 2023 - an increase of 1,295 cases. This rise in infectious diseases contributes to the expansion of the microbial identification market.

Leading companies in the microbial identification market are focusing on innovative solutions like sample preparation platforms to enhance the speed and accuracy of microbial identification. These platforms are automated systems that process and prepare biological or clinical samples for analysis, improving diagnostic efficiency and accuracy. For example, in September 2024, Accelerate Diagnostics Inc., a US-based in vitro diagnostics company, received FDA clearance for its Accelerate Arc system. This advanced automated solution is designed to rapidly identify microbes directly from positive blood culture samples. By integrating with the Bruker MALDI Biotyper CA System, it automates the sample preparation process, significantly reducing the wait time for results - critical for diagnosing and treating infections like sepsis. This system enables faster microbial identification, allowing clinicians to initiate appropriate antibiotic therapy sooner, thereby improving patient outcomes and helping mitigate antimicrobial resistance. FDA-cleared, the Accelerate Arc system aims to enhance operational efficiency within clinical laboratories.

In January 2023, Biolog Inc., a US-based provider of cellular analysis tools, acquired MIDI Inc. for an undisclosed sum. This acquisition strengthens Biolog Inc.'s capabilities in microbial identification and phenotypic profiling, expanding its offerings to deliver comprehensive microbial analysis solutions. MIDI Inc., also based in the United States, specializes in microbial identification and analysis, aligning with Biolog’s goals to enhance its microbial analysis portfolio.

Major companies operating in the microbial identification market are Merck & Co. Inc., Sanofi S A, ThermoFisher Scientific Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, Avantor Inc., Eurofins Scientific Corporation, Beckman Coulter Inc., VWR International LLC, Charles River Laboratories International Inc., Perkinelmer Inc., Wickham Micro Limited, Bruker Corporation, BioMerieux S.A., Biolog Inc., Liofilchem S.r.l, BioMérieux SA, Shimadzu Corporation, Scenker Biological Technology Co. Ltd.

North America was the largest region in the microbial identification market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbial identification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbial identification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Microbial identification involves determining and categorizing microorganisms such as bacteria, fungi, viruses, and protozoa based on their phenotypic and genotypic traits. The integration of these methods enables accurate, rapid, and comprehensive identification, critical for diagnosing, treating, and monitoring infections.

The primary product types and services for microbial identification include instruments, consumables, and services. Microbial identification instruments are devices used to detect, classify, and identify microorganisms across various applications such as diagnostic, environmental, food and beverage testing, and pharmaceutical sectors. Methods employed encompass phenotypic, proteotypic, and genotypic approaches. These solutions are utilized by diverse end users including the pharmaceutical and biotechnology industry, food and beverage industry, water and environmental industry, independent research laboratories, diagnostic laboratories, hospitals, and others.

The microbial identification market research report is one of a series of new reports that provides microbial identification market statistics, including microbial identification industry global market size, regional shares, competitors with a microbial identification market share, detailed microbial identification market segments, market trends and opportunities, and any further data you may need to thrive in the microbial identification industry. This microbial identification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microbial identification market consists of revenues earned by entities by providing services such as custom and specialized testing, clinical diagnostics, and microbial source tracking. Only goods and services traded between entities or sold to end consumers are included. The microbial identification market also consists of sales of microarray systems, genomic instruments, and culture testing instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.